{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T15:54:21Z","timestamp":1766073261290,"version":"3.48.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jem-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Emergency Medicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jemermed.2025.04.010","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T19:35:13Z","timestamp":1746473713000},"page":"43-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Latin America Multidisciplinary Consensus Panel on Management of Severe Bleeding in the Anticoagulated Patient"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0317-843X","authenticated-orcid":false,"given":"Oct\u00e1vio M.","family":"Pontes-Neto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Noble-Lugo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Cristina Montenegro","family":"Arenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joao Carlos de Campos","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Manuel","family":"Ceresetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julieta S.","family":"Rosales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Enrique","family":"Colunga-Lozano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Antonio","family":"Meillon-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Eduardo Vargas","family":"Tellez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roseny dos Reis","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Brian","family":"Gibler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie P.","family":"Kreitzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jemermed.2025.04.010_bib0001","doi-asserted-by":"crossref","first-page":"893","DOI":"10.7326\/0003-4819-139-11-200312020-00007","article-title":"Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis","volume":"139","author":"Linkins","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0002","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/hrt.2004.042465","article-title":"Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population","volume":"91","author":"Jones","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0003","article-title":"Direct oral anticoagulants compared with other strategies in patients with atrial fibrillation and stroke or transient ischemic attack: systematic review","author":"Lee","year":"2023","journal-title":"J Formos Med Assoc."},{"key":"10.1016\/j.jemermed.2025.04.010_bib0004","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0005","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3324\/haematol.2020.248542","article-title":"Biochemical, molecular and clinical aspects of coagulation factor VII and its role in hemostasis and thrombosis","volume":"106","author":"Bernardi","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0006","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMoa1814051","article-title":"Full study report of Andexanet Alfa for bleeding associated with factor xa inhibitors","volume":"380","author":"Connolly","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0007","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.annemergmed.2019.09.001","article-title":"Anticoagulant reversal strategies in the emergency department setting: recommendations of a multidisciplinary expert panel","volume":"76","author":"Baugh","year":"2020","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0008","first-page":"576","article-title":"Stroke prevention in atrial fibrillation: focus on Latin America","volume":"107","author":"Massaro","year":"2016","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0009","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/joa3.12588","article-title":"Changes in anticoagulant prescription patterns over time for patients with atrial fibrillation around the world","volume":"37","author":"Kozie\u0142","year":"2021","journal-title":"J Arrhythm"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0010","article-title":"Direct oral anticoagulants vs. Warfarin in Latin American patients with atrial fibrillation: evidence from four post-hoc analyses of randomized clinical trials","volume":"9","author":"Liu","year":"2022","journal-title":"Front Cardiovasc Med."},{"key":"10.1016\/j.jemermed.2025.04.010_bib0011","series-title":"Injury and Health Risk Management in Sports: A Guide to Decision Making","first-page":"349","article-title":"Emergency Management: ABCD (Airway, Breathing, Circulation, Disability)","author":"Ferrari","year":"2020"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0012","series-title":"Core Topics in Airway Management","first-page":"282","article-title":"The bloody and bleeding airway","author":"Kristensen","year":"2020"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0013","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1161\/STROKEAHA.113.003003","article-title":"Incidence of oral anticoagulant-associated intracerebral hemorrhage in the Netherlands","volume":"45","author":"Schols","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0014","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.chest.2017.02.009","article-title":"Direct oral anticoagulant- or warfarin-related major bleeding: characteristics, reversal strategies, and outcomes from a multicenter observational study","volume":"152","author":"Xu","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0015","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ajem.2016.09.053","article-title":"Idarucizumab and factor Xa reversal agents: role in hospital guidelines and protocols","volume":"34","author":"Huisman","year":"2016","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0016","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/bjh.19729","article-title":"Measurement of heparin, direct oral anti-coagulants and other non-coumarin anti-coagulants and their effects on haemostasis assays: A British Society for Haematology Guideline","volume":"205","author":"Baker","year":"2024","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0017","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/EJA.0000000000001968","article-title":"Clinical guideline on reversal of direct oral anticoagulants in patients with life threatening bleeding","volume":"41","author":"Grottke","year":"2024","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0018","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1182\/bloodadvances.2021004267","article-title":"ASH, ABHH, ACHO, Grupo CAHT, Grupo CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Paname\u00f1a de Hematolog\u00eda, SPH, and SVH 2021 guidelines for management of venous thromboembolism in Latin America","volume":"5","author":"Neumann","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0019","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.annemergmed.2021.06.016","article-title":"Fixed versus variable dosing of prothrombin complex concentrate for bleeding complications of vitamin K antagonists-the PROPER3 randomized clinical trial","volume":"79","author":"Abdoellakhan","year":"2022","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0020","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1002\/ajh.23202","article-title":"Guidance on the emergent reversal of oral thrombin and factor xa inhibitors","volume":"87","author":"Kaatz","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0021","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1160\/TH16-05-0363","article-title":"Managing reversal of direct oral anticoagulants in emergency situations. Anticoagulation education task force white paper","volume":"116","author":"Ageno","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0022","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1161\/CIRCULATIONAHA.115.019628","article-title":"Idarucizumab: the antidote for reversal of Dabigatran","volume":"132","author":"Eikelboom","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0023","first-page":"315","article-title":"Idarucizumab: ant\u00eddoto del dabigatr\u00e1n","volume":"22","author":"Ceresetto","year":"2018","journal-title":"Revista Hematolog\u00eda"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0024","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1182\/blood-2012-11-468207","article-title":"A specific antidote for dabigatran: functional and structural characterization","volume":"121","author":"Schiele","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0025","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJMoa1707278","article-title":"Idarucizumab for dabigatran reversal - full cohort analysis","volume":"377","author":"Pollack","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0026","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.40145","article-title":"Evaluation of direct oral anticoagulant reversal agents in intracranial hemorrhage: a systematic review and meta-analysis","volume":"5","author":"Chaudhary","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0027","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/1756283X17702092","article-title":"Direct oral anticoagulants and digestive bleeding: therapeutic management and preventive measures","volume":"10","author":"Deutsch","year":"2017","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0028","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1007\/s10620-020-06728-y","article-title":"Anticoagulant reversal in gastrointestinal bleeding: review of treatment guidelines","volume":"66","author":"Milling","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0029","first-page":"375","article-title":"Consensus document of the Spanish Society of Digestives Diseases and the Spanish Society of Thrombosis and Haemostasis on massive nonvariceal gastrointestinal bleeding and direct-acting oral anticoagulants","volume":"114","author":"Carballo","year":"2022","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0030","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1136\/gutjnl-2021-325184","article-title":"Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update","volume":"70","author":"Veitch","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0031","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1111\/jth.15466","article-title":"Anticoagulant-associated gastrointestinal bleeding: framework for decisions about whether, when and how to resume anticoagulants","volume":"19","author":"Xu","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0032","first-page":"651","article-title":"Direct-acting oral anticoagulants versus warfarin in relation to risk of gastrointestinal bleeding: a systematic review and meta-analysis of randomized controlled trials","volume":"34","author":"Aloysius","year":"2021","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0033","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1055\/a-1496-8969","article-title":"Diagnosis and management of acute lower gastrointestinal bleeding: European Society of Gastrointestinal Endoscopy (ESGE) Guideline","volume":"53","author":"Triantafyllou","year":"2021","journal-title":"Endoscopy"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0034","doi-asserted-by":"crossref","first-page":"542","DOI":"10.14309\/ajg.0000000000001627","article-title":"American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice guideline: management of anticoagulants and antiplatelets during acute gastrointestinal bleeding and the periendoscopic period","volume":"117","author":"Abraham","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0035","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s40256-023-00582-9","article-title":"Management of gastrointestinal bleeding and resumption of oral anticoagulant therapy in patients with atrial fibrillation: A multidisciplinary discussion","volume":"23","author":"Martin","year":"2023","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0036","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/jnnp-2013-306476","article-title":"Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis","volume":"85","author":"Poon","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0037","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1164\/rccm.201103-0475CI","volume":"184","author":"hemorrhage","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0038","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1212\/WNL.0000000000004174","article-title":"Severity assessment in maximally treated ICH patients: the max-ICH score","volume":"89","author":"Sembill","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0039","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1161\/STR.0000000000000407","article-title":"2022 Guideline for the management of patients with spontaneous intracerebral hemorrhage: A Guideline from the American Heart Association\/American Stroke Association","volume":"53","author":"Greenberg","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(23)00806-1","article-title":"The third Intensive care bundle with blood pressure reduction in acute cerebral haemorrhage trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial","volume":"402","author":"Ma","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0041","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1007\/s00415-019-09536-1","article-title":"Meta-analysis of haematoma volume, haematoma expansion and mortality in intracerebral haemorrhage associated with oral anticoagulant use","volume":"266","author":"Seiffge","year":"2019","journal-title":"J Neurol"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0042","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/ana.25342","article-title":"Neuroimaging and clinical outcomes of oral anticoagulant-associated intracerebral hemorrhage","volume":"84","author":"Tsivgoulis","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0043","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/ene.13742","article-title":"Fatal oral anticoagulant-related intracranial hemorrhage: a systematic review and meta-analysis","volume":"25","author":"Katsanos","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0044","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1212\/WNL.0000000000004362","article-title":"Direct oral anticoagulant- vs vitamin K antagonist-related nontraumatic intracerebral hemorrhage","volume":"89","author":"Tsivgoulis","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2020.106146","article-title":"Intracerebral hemorrhage outcomes in patients using direct oral anticoagulants versus vitamin K antagonists: a meta-analysis","volume":"198","author":"Ahmed","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0046","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/jama.2015.0846","article-title":"Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage","volume":"313","author":"Kuramatsu","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0047","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s40262-016-0485-1","article-title":"Effect of activated charcoal on Rivaroxaban complex absorption","volume":"56","author":"Ollier","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0048","unstructured":"Adsorption of Dabigatran Etexilate in Water or Dabigatran in Pooled Human Plasma by Activated Charcoal in Vitro. | Semantic Scholar. Accessed November 11, 2023. https:\/\/www.semanticscholar.org\/paper\/Adsorption-of-Dabigatran-Etexilate-in-Water-or-in-Ryn-Sieger\/0b7b0b694141fd7ba6798644385b458485232bef"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0049","unstructured":"Alexion Pharmaceuticals, Inc. A Randomized Clinical Trial of Andexanet Alfa in Acute Intracranial Hemorrhage in Patients Receiving an Oral Factor Xa Inhibitor. clinicaltrials.gov; 2023. Accessed December 31, 2023. https:\/\/clinicaltrials.gov\/study\/NCT03661528"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0050","first-page":"322","article-title":"Management dilemmas in restarting anticoagulation after gastrointestinal bleeding","volume":"35","author":"Jain","year":"2022","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0051","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1055\/s-0041-1730035","article-title":"Gastrointestinal bleeding and direct oral anticoagulants among patients with atrial fibrillation: risk, prevention, management, and quality of life","volume":"5","author":"Zappulla","year":"2021","journal-title":"TH Open"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0052","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/europace\/euab065","article-title":"2021 European Heart Rhythm Association practical guide on the use of Non-Vitamin K Antagonist oral anticoagulants in patients with atrial fibrillation","volume":"23","author":"Steffel","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0053","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/1747493019828555","article-title":"Management of oral anticoagulation after intracerebral hemorrhage","volume":"14","author":"Kuramatsu","year":"2019","journal-title":"Int J Stroke"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0054","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/0885066613488732","article-title":"Intracerebral hemorrhage in patients receiving oral anticoagulation therapy","volume":"30","author":"da Silva","year":"2015","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0055","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11883-018-0733-y","article-title":"Anticoagulation resumption after intracerebral hemorrhage","volume":"20","author":"Li","year":"2018","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0056","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/STROKEAHA.116.016327","article-title":"Restarting anticoagulant therapy after intracranial hemorrhage: A systematic review and meta-analysis","volume":"48","author":"Murthy","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0057","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/ana.25079","article-title":"Oral anticoagulation and functional outcome after intracerebral hemorrhage","volume":"82","author":"Biffi","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0058","article-title":"Meta-analysis of oral anticoagulants and adverse outcomes in atrial fibrillation patients after intracranial hemorrhage","volume":"9","author":"Liu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0059","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S1474-4422(21)00024-7","volume":"20","author":"Best","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0060","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1161\/STROKEAHA.110.593087","article-title":"Optimal timing of resumption of warfarin after intracranial hemorrhage","volume":"41","author":"Majeed","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0061","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/STROKEAHA.116.014643","article-title":"Optimal timing of anticoagulant treatment after intracerebral hemorrhage in patients with atrial fibrillation","volume":"48","author":"Pennlert","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0062","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.athoracsur.2019.01.016","article-title":"Reversal and resumption of antithrombotic therapy in LVAD-associated intracranial hemorrhage","volume":"108","author":"Cho","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0063","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/eurheartj\/ehy056","article-title":"Management of therapeutic anticoagulation in patients with intracerebral haemorrhage and mechanical heart valves","volume":"39","author":"Kuramatsu","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0064","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-Year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0065","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0140-6736(23)02025-1","article-title":"Anticoagulation in patients with cerebral amyloid angiopathy","volume":"402","author":"Shoamanesh","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.htct.2024.01.002","article-title":"Hemorrhagic code protocol, a successful case in the patient blood management model for patients with severe hemorrhages","author":"Guerra","year":"2024","journal-title":"Hematol Transfus Cell Ther"},{"key":"10.1016\/j.jemermed.2025.04.010_bib0067","doi-asserted-by":"crossref","first-page":"eAO5032","DOI":"10.31744\/einstein_journal\/2020AO5032","article-title":"Manejo de sangramento ap\u00f3s implanta\u00e7\u00e3o do C\u00f3digo Hemorr\u00e1gico (C\u00f3digo H) no Hospital Israelita Albert Einstein","volume":"18","author":"Jaures","year":"2020","journal-title":"S\u00e3o Paulo, Brasil. einstein (S\u00e3o Paulo)"}],"container-title":["The Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467925001350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467925001350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T15:49:21Z","timestamp":1766072961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0736467925001350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":67,"alternative-id":["S0736467925001350"],"URL":"https:\/\/doi.org\/10.1016\/j.jemermed.2025.04.010","relation":{},"ISSN":["0736-4679"],"issn-type":[{"type":"print","value":"0736-4679"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Latin America Multidisciplinary Consensus Panel on Management of Severe Bleeding in the Anticoagulated Patient","name":"articletitle","label":"Article Title"},{"value":"The Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemermed.2025.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}